AprilBio Co.,Ltd. (KOSDAQ: 397030)

Market Cap	352.24B
Revenue	n/a
Net Income	n/a
Shares Out	22.44M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	170,836
Average Volume	224,544
Open	15,600
Previous Close	15,530
Day's Range	15,580 - 16,170
52-Week Range	11,510 - 25,900
Beta	1.58
RSI	44.68
Earnings Date	n/a

About AprilBio Co.,Ltd.

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2013
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 397030